Companies partner to perform trials of antimicrobial topical treatmentJanuary 9, 2019Stonehaven Incubate and antimicrobial protein specialist Lysando have agreed to jointly conduct proof-of-concept trials for new topical treatments based on Artilysin, a new antimicrobial platform technology.
SPONSORED CONTENTNutrition to improve mobility in dogsNutrition that helps support joint cartilage preservation and is clinically proven to improve mobility in as little as 3 weeks. + Learn More